Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia

Blood

Volumn 94, Issue 6, 1999, Pages 2056-2064

  Holyoake, Tessa ^a   Jiang, Xiaoyan ^a   Eaves, Connie ^a   Eaves, Allen ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HOE 33342; INTERLEUKIN 3; INTERLEUKIN 6; PYRONINE; STEEL FACTOR;

ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL SUBPOPULATION; CHRONIC MYELOID LEUKEMIA; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

EID: 0033568250     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.6.2056.418k13_2056_2064     Document Type: Article

References (52)

1. Raskind WH, Fialkow PJ: The use of cell markers in the study of human hematopoietic neoplasia. Adv Cancer Res 49:127, 1987
2. Eaves AC, Barnett MJ, Ponchio L, Cashman JD, Petzer A, Eaves CJ: Differences between normal and CML stem cells: Potential targets for clinical exploitation. Stem Cells 16:77, 1998
3. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
4. Groffen J, Stephenson JR, Heisterkamp N, De Klein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984
5. Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E: Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277, 1986
6. Strife A, Lambek C, Wisniewski D, Wachter M, Gulati SC, Clarkson BD: Discordant maturation as the primary biological defect in chronic myelogenous leukemia. Cancer Res 48:1035, 1988
7. Bedi A, Zehnbauer BA, Barber J, Sharkis S, Jones R: Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83:2038, 1994
8. Maguer-Satta V, Burl S, Liu L, Damen J, Chahine H, Krystal G, Eaves A, Eaves C: BCR-ABL accelerates C2-ceramide-induced apoptosis. Oncogene 16:237, 1998
9. Jiang X, Lopez A, Holyoake T, Eaves A, Eaves C: Autocrine production and action of IL-3 and G-CSF in chronic myeloid leukemia, (submitted)
10. Eaves CJ, Eaves AC: Cell culture studies in CML, in Hinton K (ed): Bailliere's Clinical Haematology. London, UK, Bailliere Tindall, Saunders, 1987, p931
11. + cells. Br J Haematol 102:759, 1998
12. Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett MJ, Eaves AC: Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc Natl Acad Sci USA 89:6192, 1992
13. Petzer AL, Eaves CJ, Barnett MJ, Eaves AC: Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Blood 90:64, 1997
14. Ponchio L, Eaves CJ: Very primitive hematopoietic cells (LTC-IC) in normal adult human blood and marrow show differences in the regulation of their cycling state. Blood 86:493a, 1995 (abstr, suppl 1)
15. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ: Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 94:4698, 1997
16. Kantarjian HM, Vellekoop L, McCredie KB, Keating MJ, Hester J, Smith T, Barlogie B, Trujillo J, Freireich EJ: Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia. J Clin Oncol 3:192, 1985
17. + chronic myelogenous leukemia and effects of intensive treatment. Blood 59:793, 1982
18. Shapiro HM: Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and Pyronin Y. Cytometry 2:143, 1981
19. 0. Blood 90:658, 1997
20. 1 phase of the cell cycle. Blood 90:4384, 1997
21. - cell production in vitro. Br J Haematol 98:528, 1997
22. Holyoake TL, Cameron G, Horrocks C, Thomas T, Eaves C, Eaves A: Development of immunomagnetic negative depletion procedures for obtaining enriched populations of primitive cells from CML blood samples or their progeny regenerated in NOD/SCID mice. Exp Hematol 26:757, 1998 (abstr)
23. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
24. Jordan CT, Yamasaki G, Minamoto D: High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol 24:1347, 1996
25. + subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 91:12223, 1994
26. + cells from patients with chronic myeloid leukemia. Blood 88:1796, 1996
27. Hogge DE, Lansdorp PM, Reid D, Gerhard B, Eaves CJ: Enhanced detection, maintenance and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human Steel factor, interleukin-3 and granulocyte colony-stimulating factor. Blood 88:3765, 1996
28. Petzer AL, Eaves CJ, Lansdorp PM, Ponchio L, Barnett MJ, Eaves AC: Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 88:2162, 1996
29. 2-microglobulin-deficient NOD-scid mice. J Immunol 158:3578, 1997
30. Schluter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Had H-D, Gerdes J: The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining protein. J Cell Biol 123:513, 1993
31. 1 cyclins. Cell 73:1059, 1993
32. Fraser C, Eaves CJ, Kalousek DK: Fluorodeoxyuridine synchronization of hemopoietic colonies. Cancer Genet Cytogenet 24:1, 1987
33. Cashman J, Bockhold K, Hogge DE, Eaves AC, Eaves CJ: Sustained proliferation, multi-lineage differentiation and maintenance of primitive human haematopoietic cells in NOD/SCID mice transplanted with human cord blood. Br J Haematol 98:1026, 1997
34. Conneally E, Cashman J, Petzer A, Eaves C: Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA 94:9836, 1997
35. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE: Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94:5320, 1997
36. - bone marrow cells with multilineage potential at the single-cell level: Key role of thrombopoietin. Blood 90:2282, 1997
37. Pellicciari C, Mangiarotti R, Bottone MG, Danova M, Wang E: Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content. Cytometry 21:329, 1995
38. Schneider C, King RM, Philipson L: Genes specifically expressed at growth arrest of mammalian cells. Cell 54:787, 1988
39. Wang E: A 57,000-mol-wt protein uniquely present in nonproliferating cells and senescent human fibroblasts. J Cell Biol 100:545, 1985
40. Celis JE, Bravo R, Larsen PM, Fey SJ: Cyclin: A nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res 8:143, 1984
41. Ponchio L, Conneally E, Eaves C: Quantitation of the quiescent fraction of longterm culture-initiating cells (LTC-IC) in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro. Blood 86:3314, 1995
42. Habibian HK, Peters SO, Hsieh CC, Wuu J, Vergilis K, Grimaldi CI, Reilly J, Carlson JE, Frimberger AE, Stewart FM, Quesenberry PJ: The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit. J Exp Med 188:393, 1998
43. + cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92:2641, 1998
44. Wang JCY, Lapidot T, Cashman JD, Doedens M, Addy L, Sutherland DR, Nayar R, Laraya P, Minden M, Keating A, Eaves AC, Eaves CJ, Dick JE: High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 91:2406, 1998
45. + cells. Blood 91:630, 1998
46. Dazzi F, Capelli D, Hasserjian R, Cotter F, Corbo M, Poletti A, Chinswangwatanakul W, Goldman JM, Gordon MY: The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: An in vivo model of chronic myelogenous leukemia biology. Blood 92:1390, 1998
47. Cashman JD, Eaves AC, Eaves CJ: Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-β on normal and leukemic human hematopoietic progenitor cells. Leukemia 6:886, 1992
48. Eaves CJ, Cashman JD, Wolpe SD, Eaves AC: Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1α, an inhibitor of primitive normal hematopoietic cells. Proc Natl Acad Sci USA 90:12015, 1993
49. Cashman JD, Eaves CJ, Sarris AH, Eaves AC: MCP-1, not MIP-1α is the endogenous chemokine that cooperates with TGF-β to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures. Blood 92:2338, 1998
50. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
51. Zandstra PW, Conneally E, Piret JM, Eaves CJ: Ontogeny-associated changes in the cytokine responses of primitive human haematopoietic cells. Br J Haematol 101:770, 1998
52. Cashman JD, Clark-Lewis I, Eaves AC, Eaves CJ: Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model. Blood (in press)